BCYC
Bicycle Therapeutics Ltd
NASDAQ: BCYC · HEALTHCARE · BIOTECHNOLOGY
$4.72
-0.21% today
Updated 2026-04-30
Market cap
$337.89M
P/E ratio
—
P/S ratio
4.66x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $10
Volume
0.5M
Bicycle Therapeutics Ltd (BCYC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.27M | $-1.42M | $-26.08M | $-28.61M | $-17.79M | $-14.79M | $-86.11M | $-60.63M | $-164.72M | $-249.68M |
| Capital expenditures | $243358.00 | $1.11M | $1.19M | $1.55M | $1.20M | $2.03M | $18.99M | $2.93M | $1.24M | $2.36M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $123000.00 | $515000.00 | $1.02M | $3.08M | $6.51M | $12.08M | $26.78M | $32.48M | $38.08M | $39.46M |
| Free cash flow | $-11.51M | $-2.53M | $-27.26M | $-30.17M | $-18.99M | $-16.82M | $-105.10M | $-63.56M | $-165.96M | $-252.03M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |